Table 3

Drug glucuronidation by human tissue microsomes

CompoundHepaticIntestinalRenalTotal
CLintCLCLintCLCLCL
μl/min/mg ml/min/kg μl/min/mg ml/min/kg ml/min/kg ml/min/kg
Codeine0.41, 0.480.41N.D.00.41
Ethinylestradiol0.54, 0.760.051.3  ± 0.640.01N.D.0.07
Furosemide0.13, 0.120.0070.07  ± 0.030.00040.007
Gemfibrozil2.4  ± 0.30.201.83  ± 0.280.020.210.42
Imipramine0.39, 0.410.300.020.32
Ketoprofen0.23, 0.210.020.20  ± 0.030.0020.060.08
Morphine2.0, 1.91.3N.D.00.471.8
Naloxone0.55  ± 0.10.370.21  ± 0.070.010.430.81
Naproxen0.38  ± 0.040.010.31  ± 0.080.0010.010.02
Propofol1.4, 3.30.831.1  ± 0.180.041.32.2
Valproic acid0.21, 0.190.030.06  ± 0.020.0010.020.06

CLint estimates for liver are reproduced from Soars et al. (2001). Renal CL was scaled from CLint estimates obtained previously (Soars et al., 2001). Values for intestine are mean ± S.D. obtained from three separate experiments. Scaled CL was determined using the well stirred model (see Materials and Methods).

  • N.D., below the level of detection (8 pmol/min/mg); —, not determined.